Date: 2016-02-03
Type of information: Nomination
Compound:
Company: The Medicines Company (USA - NJ)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On February 3, 2016, The Medicines Company announced that it has appointed Alexander J. Denner, Ph.D. to its Board of Directors. Dr. Denner will serve as a Class III director with a term expiring at the Company’s 2018 Annual Meeting of Stockholders. He will also serve on the Company’s Nominating and Corporate Governance Committee. With the appointment of Dr. Denner, which was effective on February 2, 2016, the Company’s Board of Directors is comprised of 11 directors, ten of whom are independent. Dr. Denner is the chief investment officer of Sarissa Capital Management LP, a registered investment advisor, which he founded in 2012. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital, an entity through which Carl C. Icahn conducts his investment activities. Prior to that, he served as a portfolio manager at Viking Global Investors, a private investment fund, and Morgan Stanley Investment Management, a global asset management firm. Dr. Denner currently serves as a director of Biogen Inc. and Chairman of ARIAD Pharmaceuticals, Inc., both biopharmaceutical companies. Dr. Denner also previously served as a director of the following life sciences companies: Amylin Pharmaceuticals, Inc., VIVUS, Inc., Enzon Pharmaceuticals, Inc. and ImClone Systems Incorporated, where he also served as Chairman of the Executive Committee. Dr. Denner has extensive experience overseeing the operations and research and development of healthcare companies. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge. Dr. Denner received his S.B. degree from the Massachusetts Institute of Technology and his M.S., M.Phil. and Ph.D. degrees from Yale University.
Financial terms:
Latest news:
